GlobeStar Therapeutics Corporation
GSTC · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $84 | $148 | $0 | $0 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $84 | $148 | $0 | $0 |
| Liabilities | – | – | – | – |
| Payables | $435 | $408 | $366 | $328 |
| Short-Term Debt | $329 | $336 | $375 | $366 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$586 | $0 | $0 |
| Other Curr. Liab. | $62 | $648 | $60 | $60 |
| Total Curr. Liab. | $1,709 | $1,616 | $1,533 | $1,434 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,709 | $1,616 | $1,533 | $1,434 |
| Equity | – | – | – | – |
| Pref Stock | $1 | $1 | $1 | $1 |
| Common Stock | $1,241 | $1,163 | $1,050 | $996 |
| Retained Earnings | -$21,023 | -$20,825 | -$20,650 | -$20,454 |
| AOCI | $179 | $179 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$1,625 | -$1,469 | -$1,533 | -$1,434 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $84 | $148 | $0 | $0 |
| Net Debt | $329 | $336 | $375 | $366 |